Home
About
Overview
Sharing Data
ORCID
Help
History (22)
Association of Circulating Tumor DNA and Circulating Tumor Cells After Neoadjuvant Chemotherapy With Disease Recurrence in Patients With Triple-Negative Breast Cancer: Preplanned Secondary Analysis of the BRE12-158 Randomized Clinical Trial.
Variability in Hourly Activity Levels: Statistical Noise or Insight Into Older Adult Frailty?
Leptin deficiency and beta-cell dysfunction underlie type 2 diabetes in compound Akt knockout mice.
Persistent Hyperplastic Primary Vitreous
Pharmacogenetics and pharmacogenomics: a bridge to individualized cancer therapy.
See All 22 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Pharmacogenetics and pharmacogenomics: a bridge to individualized cancer therapy.
Pharmacogenetics and pharmacogenomics: a bridge to individualized cancer therapy. Pharmacogenomics. 2013 Feb; 14(3):315-24.
View in:
PubMed
subject areas
Antineoplastic Agents
Capecitabine
Deoxycytidine
Drug Discovery
Fluorouracil
Genetic Variation
Humans
Mercaptopurine
Methyltransferases
Neoplasms
Pharmacogenetics
Polymorphism, Single Nucleotide
Precision Medicine
authors with profiles
Liming Weng